Is Singapore Worth Exploring for Cancer Care?
Singapore has major academic cancer centres and three reported proton therapy facilities. It also offers selected approved cancer treatments and structured services for international patients.
However, having advanced equipment or specialist services does not automatically make Singapore the right destination for every patient. This guide examines Singapore's documented cancer-care capabilities, treatment access, published cost information, and practical considerations for international patients.
The purpose is not to promote Singapore or rank hospitals. It is to help patients and families identify what needs to be verified before considering treatment abroad.
Quick Answer
Singapore has reported proton therapy facilities and major academic cancer centres. It also has selected approved cell and gene therapy products. Costs are generally higher than in several other Asian destinations, and published price information is limited and not directly comparable across centres.
For an investigational cellular therapy, start with the specific study — not a country label. Check the intervention, trial phase, recruiting site, eligibility criteria, and whether international participation is possible.
"Singapore offers established proton therapy services and major academic cancer centres, but the value of travelling there depends on the treatment required, the available alternatives, and the total cost."
Three Questions to Consider Before Exploring Singapore
These questions are intended to help you identify what needs further investigation. They do not assess medical suitability, recommend a treatment, or select a country for an individual patient.
1. What is the main medical question?
Are you seeking an additional specialist opinion, a specific type of radiotherapy, an approved medicine or cellular therapy, or an eligible clinical trial?
The answer determines which hospital department or service you may need to contact.2. What evidence and access status does the proposed treatment have?
Clarify whether the treatment is an established standard, an approved treatment for a specific indication, an approved treatment that may not be available to international patients, an investigational treatment in a clinical trial, or an early-stage or unproven approach.
These categories are not interchangeable. Availability in a country does not establish suitability for a particular patient.3. What is the realistic total cost and travel burden?
Consider hospital charges and additional tests, expected duration, accommodation and companion expenses, flights, possible complications, and follow-up after returning home.
Request a written estimate and confirm the expected treatment schedule before making travel arrangements.Proton Therapy in Singapore: Three Reported Treatment Centres
Singapore has three reported proton therapy facilities. The number of treatment gantries indicates facility capacity; it does not establish comparative treatment quality, clinical outcomes, or suitability for an individual patient.
| Centre | Sector | Treatment gantries |
|---|---|---|
| Goh Cheng Liang Proton Therapy Centre, National Cancer Centre Singapore (NCCS) | Public | 4 |
| Mount Elizabeth Novena Hospital | Private | 1 |
| Singapore Institute of Advanced Medicine Holdings (SAM), Biopolis | Private | 1 |
NCCS is the only public healthcare institution in Singapore offering proton therapy. The other two facilities are private.
International patients should confirm current treatment availability, eligibility, appointment access, and pricing directly with the relevant centre before making travel arrangements.
What Clinical Evidence Can — and Cannot — Tell You
Proton therapy may be considered for selected patients when treatment planning suggests that it could reduce radiation exposure to nearby critical organs compared with an appropriate photon-based plan. This may be relevant in some childhood cancers and in selected tumours involving the brain, skull base, spinal region, or other anatomically sensitive areas.
However, tumour location alone does not determine whether proton therapy is appropriate. The decision requires an individual comparison of treatment plans, expected tumour control, dose to surrounding organs, potential side effects, treatment duration, and cost. Modern photon radiotherapy, including IMRT, remains an effective standard option for many cancers.
A US multicentre randomised phase 3 trial compared IMPT with IMRT in 440 patients with oropharyngeal cancer. It met its primary non-inferiority endpoint for progression-free survival and reported higher five-year overall survival estimates and lower rates of several high-grade toxicities with IMPT. Not all participants received their allocated treatment, and the findings apply to this study population and treatment setting — not to every cancer or to the comparative quality of Singapore's centres.
These findings are important, but they do not establish that proton therapy is superior for every cancer type or every patient. The choice between proton therapy and photon-based radiotherapy should be based on an individual treatment-plan comparison and the evidence relevant to the patient's diagnosis.
Reference: Frank SJ et al. The Lancet. 2026;407(10524):174–184. Published online December 2025. DOI: 10.1016/S0140-6736(25)01962-2.
Cellular Therapy and Clinical Trial Access
Singapore has access to selected approved cell and gene therapy products. Regulatory approval, public funding, and hospital availability are separate questions:
- Regulatory approval: Check the product's registration and approved indication with the Health Sciences Authority (HSA).
- Public funding: Check funding criteria and eligibility with the Ministry of Health (MOH). The MOH Cell, Tissue and Gene Therapy Product list relates to subsidy eligibility at public institutions for eligible citizens and residents — it is not a comprehensive list of regulatory approvals.
- Hospital availability: Confirm with the treating centre whether the product is currently available and whether international patients are accepted.
The presence of an approved product does not mean that every international patient can access it. Eligibility, treatment availability, funding arrangements, and hospital acceptance must be confirmed directly. The absence of a product from the MOH subsidy list does not, by itself, mean the product is unapproved.
For an investigational cellular therapy, start with the specific study, not a country label. Verify:
- Whether the study is registered and currently recruiting
- Whether the patient's cancer type and treatment history meet the eligibility criteria
- Whether international participants are accepted
- Whether the treatment is investigational or approved
- Which costs are covered by the sponsor and which remain the patient's responsibility
The size of a country's overall clinical-trial registry is not a reliable substitute for checking relevant, currently recruiting cancer trials.
Understanding Proton Therapy Costs in Singapore
Proton therapy is a high-cost treatment, and the total price depends on the diagnosis, treatment plan, number of fractions, planning requirements, and the treating centre. Publicly reported prices are not directly comparable because they may refer to different years, patient categories, treatment protocols, and package inclusions.
| Centre | Published price information | Important limitation |
|---|---|---|
| Mount Elizabeth Novena | Approximately SGD 60,000–70,000, reported in May 2023 | Historical figure; not a confirmed 2026 quotation |
| Singapore Institute of Advanced Medicine Holdings (SAM) | Request a current quotation directly from the centre | No verified current public price is provided here |
| National Cancer Centre Singapore (NCCS) | Current international-patient pricing should be requested directly | No verified current public international-patient price is provided here |
These figures are reference points, not guaranteed prices.
What Should a Written Estimate Include?
Before arranging travel, ask the treating centre for an itemised estimate covering:
- Initial consultation and specialist assessment
- Treatment planning, imaging, and simulation
- Proton therapy sessions and the expected number of fractions
- Any additional medical procedures or medication
- Hospital admission, if required
- Management of treatment-related complications
- Follow-up consultations and imaging
- Any services not included in the quoted package
Also ask whether the quotation applies to international self-paying patients and whether additional sessions or treatment-plan changes could increase the total.
Accommodation, flights, local transport, and companion expenses should be calculated separately. A published price range is useful for initial planning, but only a written estimate from the treating centre can clarify the likely cost of an individual treatment course.
Questions to Compare Across Centres and Countries
Different countries offer different combinations of treatment availability, clinical research, hospital infrastructure, cost, and international-patient services. The following comparison is a starting point for research, not a ranking of countries or hospitals.
| Evaluation area | What to verify in Singapore | What to compare internationally |
|---|---|---|
| Proton therapy | Three reported facilities: NCCS, Mount Elizabeth Novena, and SAM | Current licensed facilities, indications, treatment-plan quality, and international-patient access |
| CAR-T therapy | Products listed by Singapore's Ministry of Health for subsidy eligibility include Kymriah and Yescarta for specific indications; confirm regulatory status with HSA | National approvals, product indications, hospital availability, and eligibility for international patients |
| Experimental cellular therapy | Identify the exact registered trial and current recruitment status | Trial phase, recruiting centres, inclusion criteria, international participation, and sponsor coverage |
| Cancer surgery | Identify the relevant surgical specialty and hospital experience | Outcomes for comparable patients, complications, and treatment alternatives |
| Treatment cost | Request an itemised international-patient estimate | Total cost for the same treatment pathway, including accommodation and follow-up |
| Language and coordination | Confirm English-language services and international-patient support with the hospital | Availability of interpretation, medical coordination, and written communication |
| Follow-up | Confirm arrangements after the patient returns home | Whether the treating hospital can coordinate follow-up with the patient's local oncologist |
Travel and Entry Requirements for Medical Treatment
Singapore does not use one universal medical-treatment visa category for all international patients. Entry requirements depend on the travel document and nationality of the visitor.
Some travellers must obtain a Singapore entry visa before travelling, while others may not require one. A valid entry visa does not guarantee admission; the final decision is made by Singapore's immigration authorities.
Eligible visitors may receive a Short-Term Visit Pass upon arrival. Visitors who need additional time for medical treatment may apply for an extension, subject to ICA requirements and supporting documents.
If treatment may extend beyond your permitted stay, check ICA's extension requirements in advance, including medical documentation and any local-sponsor requirement. Applying for an extension does not itself authorise an overstay.
Before travelling:
- Check whether your passport requires a Singapore entry visa.
- Confirm the expected treatment duration with the hospital.
- Ask the hospital whether it can provide appointment or treatment documentation.
- Check the latest entry and stay requirements with Singapore's Immigration & Checkpoints Authority (ICA).
The SG Arrival Card is also required for most arriving foreign visitors and is not a visa.
Official information: Singapore Immigration & Checkpoints Authority (ICA).
Continue Your Research
Explore related CancerCareE resources:
South Korea
Cancer treatment access and documented capabilities
China
Treatment access, clinical trials, and regulatory information
Proton Therapy
Evidence, indications, and treatment considerations
CAR-T Therapy
Approved products, eligibility, and clinical research
Cancer Treatment Costs
Understanding medical and non-medical expenses
Where an English-language version is not yet available, the linked resource will be clearly identified as Persian-language content.
Frequently Asked Questions
How many proton therapy centres are there in Singapore?
Three reported facilities: NCCS (public, 4 treatment gantries), Mount Elizabeth Novena (private, 1 gantry), and SAM at Biopolis (private, 1 gantry). NCCS is the only public institution offering proton therapy — not the only institution overall. The number of gantries indicates facility capacity; it does not establish comparative treatment quality.
How much does proton therapy cost in Singapore?
Published price information is limited and not directly comparable across centres. Mount Elizabeth Novena reported approximately SGD 60,000–70,000 in May 2023 — a historical figure, not a current quotation. NCCS and SAM do not publish verified current international-patient pricing; contact them directly for a written estimate. These figures are reference points, not guaranteed prices.
Does NCCS provide proton therapy services to international patients?
NCCS publishes dedicated contact details for foreign patients seeking information or appointments at its Goh Cheng Liang Proton Therapy Centre. International patients can contact the Patient Liaison Service to ask about appointment availability, the medical assessment process, and applicable charges. The centre must determine whether it can assess the patient's case and whether proton therapy is appropriate. Contacting the centre does not guarantee acceptance or treatment.
If medical records are required, the patient should submit them directly to the hospital through its designated secure process. CancerCareE does not receive or collect medical records.
How does Singapore compare to South Korea for cancer treatment?
Singapore and South Korea offer different combinations of treatment availability, clinical research, hospital infrastructure, cost, and international-patient services. Singapore has reported proton therapy facilities and English-language coordination. South Korea has documented surgical outcomes at major centres and selected approved cellular therapies. The right choice depends on the specific clinical question, not on a general country ranking.
What entry requirements apply for cancer treatment in Singapore?
Singapore does not use one universal medical-treatment visa category. Entry requirements depend on your travel document and nationality. Some travellers must obtain an entry visa before travelling; others may not require one. Eligible visitors may receive a Short-Term Visit Pass upon arrival; extensions for medical treatment are subject to ICA requirements. Confirm the latest entry and stay requirements with Singapore's Immigration & Checkpoints Authority before travelling.
How is CancerCareE funded?
CancerCareE does not charge patients for general information and does not receive referral commissions from hospitals or clinics. If this model changes, this page and the financial transparency page will be updated together.
Ask About a Page or Public Source
If you are researching cancer treatment access in Singapore, CancerCareE can help you understand publicly available information about treatment access, regulatory status, hospital services, and international-patient arrangements.
Which page, term, or public source would you like us to explain or correct?
Please do not include a diagnosis, medical history, prescription, test result, or other personal health information.
If you need a hospital to review your medical case, contact that institution directly and follow its own secure submission process.
CancerCareE does not diagnose, recommend treatment, or determine clinical suitability. There is no fee for accessing CancerCareE's general information.